Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c
Tweet
Share
E-mailGet Alerts CDTX Hot Sheet
Join SI Premium – FREE
Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
- Twin Disc (TWIN) Tops Q4 EPS by 16c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
